![]() |
|
|
Vol. 59, Issue 1, 16-23, January 2001
Department of Physiology & Cell Biology, University of
Nevada School of Medicine, Reno, Nevada
Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites
of cytochrome P450 monooxygenase, which are released from endothelial
cells and dilate arteries. Dilation seems to be caused by activation of
large-conductance Ca2+-activated K+ channels
(BKCa) leading to membrane hyperpolarization. Previous studies suggest that EETs activate BKCa channels via
ADP-ribosylation of the G protein G
s with a subsequent
membrane-delimited action on the channel [Circ Res
78:415-423, 1996; 80:877-884, 1997;
85:349-356, 1999]. The present study examined whether this
pathway is present in human embryonic kidney (HEK) 293 cells when the
BKCa
-subunit (cslo-
) is
expressed without the
-subunit. 11,12-EET increased outward
K+ current in whole-cell recordings of HEK293
cells. In cell-attached patches, 11,12-EET also increased the activity
of cslo-
channels without affecting unitary conductance.
This action was mimicked by cholera toxin. The ADP-ribosyltransferase
inhibitors 3-aminobenzamide and m-iodobenxylguanidine
blocked the stimulatory effect of 11,12-EET. In inside-out patches
11,12-EET was without effect on channel activity unless GTP was
included in the bathing solution. GTP and GTP
S alone also activated
cslo-
channels. Dialysis of cells with anti-G
s
antibody completely blocked the activation of cslo-
channels by 11,12-EET, whereas anti-G
i/o and anti-G
antibodies were without effect. The protein kinase A inhibitor KT5720 and the
adenylate cyclase inhibitor SQ22536 did not reduce the stimulatory effect of 11,12-EET on cslo-
channels in cell-attached
patches. These data suggest that EET leads to G
s-dependent
activation of the cslo-
subunits expressed in HEK293
cells and that the cslo-
subunit is not required.
This article has been cited by other articles:
![]() |
W. Yang, B. B. Holmes, V. R. Gopal, R. V. K. Kishore, B. Sangras, X.-Y. Yi, J. R. Falck, and W. B. Campbell Characterization of 14,15-Epoxyeicosatrienoyl-Sulfonamides as 14,15-Epoxyeicosatrienoic Acid Agonists: Use for Studies of Metabolism and Ligand Binding J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1023 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ye, W. Zhou, T. Lu, S. G. Jagadeesh, J. R. Falck, and H.-C. Lee Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1326 - H1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sakamoto, T. Nonomura, S. Ohya, K. Muraki, T. Ohwada, and Y. Imaizumi Molecular Mechanisms for Large Conductance Ca2+-Activated K+ Channel Activation by a Novel Opener, 12,14-Dichlorodehydroabietic Acid J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 144 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sade, K. Muraki, S. Ohya, N. Hatano, and Y. Imaizumi Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids Am J Physiol Cell Physiol, January 1, 2006; 290(1): C77 - C86. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xi, D. Tcheranova, H. Parfenova, B. Horowitz, C. W. Leffler, and J. H. Jaggar Carbon monoxide activates KCa channels in newborn arteriole smooth muscle cells by increasing apparent Ca2+ sensitivity of {alpha}-subunits Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H610 - H618. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Begg, F.-M. Mo, L. Offertaler, S. Batkai, P. Pacher, R. K. Razdan, D. M. Lovinger, and G. Kunos G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current J. Biol. Chem., November 14, 2003; 278(46): 46188 - 46194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Falck, U. M. Krishna, Y. K. Reddy, P. S. Kumar, K. M. Reddy, S. B. Hittner, C. Deeter, K. K. Sharma, K. M. Gauthier, and W. B. Campbell Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H337 - H349. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Snyder, U. M. Krishna, J. R. Falck, and A. A. Spector Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1936 - H1942. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imaizumi, K. Sakamoto, A. Yamada, A. Hotta, S. Ohya, K. Muraki, M. Uchiyama, and T. Ohwada Molecular Basis of Pimarane Compounds as Novel Activators of Large-Conductance Ca2+-Activated K+ Channel alpha -Subunit Mol. Pharmacol., October 1, 2002; 62(4): 836 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lauterbach, E. Barbosa-Sicard, M.-H. Wang, H. Honeck, E. Kargel, J. Theuer, M. L. Schwartzman, H. Haller, F. C. Luft, M. Gollasch, et al. Cytochrome P450-Dependent Eicosapentaenoic Acid Metabolites Are Novel BK Channel Activators Hypertension, February 1, 2002; 39(2): 609 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, C. L. Oltman, T. Lu, H.-C. Lee, K. C. Dellsperger, and M. VanRollins EET homologs potently dilate coronary microvessels and activate BKCa channels Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2430 - H2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Dick, C. F. Rossow, S. Smirnov, B. Horowitz, and K. M. Sanders Tamoxifen Activates Smooth Muscle BK Channels through the Regulatory beta 1 Subunit J. Biol. Chem., September 7, 2001; 276(37): 34594 - 34599. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Campbell, C. Deeter, K. M. Gauthier, R. H. Ingraham, J. R. Falck, and P.-L. Li 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1656 - H1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, D. X. Zhang, Z.-D. Ge, and W. B. Campbell Role of ADP-ribose in 11,12-EET-induced activation of KCa channels in coronary arterial smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1229 - H1236. [Abstract] [Full Text] [PDF] |
||||